EODData

NASDAQ, OBIO: Orchestra Biomed Hldgs Inc

07 Nov 25 15:59
LAST:

3.800

CHANGE:
 0.00
OPEN:
3.770
HIGH:
3.850
ASK:
0.000
VOLUME:
269.3K
CHG(%):
0.00
PREV:
3.810
LOW:
3.470
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 253.7703.8503.4703.810326.4K
06 Nov 253.9204.0203.7903.810306.1K
05 Nov 253.7903.9403.7123.920280.3K
04 Nov 253.8603.9503.6703.740186.7K
03 Nov 253.8503.9903.7703.950246.9K
31 Oct 253.9904.0003.8103.900138.9K
30 Oct 253.6104.0103.5404.010313.6K
29 Oct 253.8303.8303.5603.610247.2K
28 Oct 253.9803.9803.7103.790229.8K
27 Oct 253.9604.1003.7503.950392.3K

COMPANY PROFILE

Name:Orchestra Biomed Hldgs Inc
About:Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications; and CNT-HF, a bioelectronic product candidate that aims to reduce chronic sympathetic nervous system activity in heart failure. In addition, the company offers FreeHold devices and additional minimally invasive surgery enabling devices; and Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper gastrointestinal endoscopy procedures. It has a collaboration agreement with Medtronic, Inc. for the development of AVIM therapy for the treatment of HTN in pacemaker-indicated patients; and a strategic collaboration with Terumo Corporation and Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. was founded in 2018 and is headquartered in New Hope, Pennsylvania.
Sector:Healthcare
Industry:Biotechnology
Address:150 Union Square Drive, New Hope, PA, United States, 18938
Website:https://orchestrabiomed.com
CUSIP:68572M106
CIK:0001814114
ISIN:US68572M1062
FIGI:BBG00W5FR2T5

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-2.38 
Forward P/E:-2.22 
PEG Ratio:-0.21 
Price to Sales:71.48 
Price to Book:487.50 
Profit Margin:0.92 
Operating Margin:-23.12 
Return on Assets:-0.77 
Return on Equity:-3.14 
EPS Ratio:-1.83 
Revenue:2.94M 
Shares:53.96M 
Market Cap:205.03M 

TECHNICAL INDICATORS

MA5:3.851.2%
MA10:3.851.3%
MA20:3.751.3%
MA50:3.0823.5%
MA100:2.9827.6%
MA200:3.3613.1%
STO9:48.78
STO14:46.30
RSI14:47.91
WPR14:-44.44
MTM14:-0.08
ROC14:-0.02 
ATR:0.31 
Week High:4.025.8%
Week Low:3.479.5%
Month High:4.107.9%
Month Low:2.6613.1%
Year High:6.5071.1%
Year Low:2.2072.7%